Conversely, inhibition of RBM25 (HF + sh‐RBM25 group) led to a significant reduction in myocardial infarction area compared to the HF + sh‐NC group (p < 0.01, Figure 3A). The gene discussed is RBM25; the disease is myocardial infarction.